Yijing Capital ^Investors

Yijing Capital is an investment company based in Shanghai, China. Founded in 2015, the company primarily focuses on investments in the medical and health-care sector. Operating in the Asia-Pacific (APAC) region, Yijing Capital has established itself as a prominent player in the biotech, pharma, and Biomed industries. One of their notable investments includes Artivila Therapeutics, showcasing their commitment to supporting innovative companies in these fields. With its strategic location in Shanghai, Yijing Capital is well-positioned to tap into the thriving healthcare market in the APAC region.